Cleared Special

K090102 - NIAGARA, NIAGARA SLIM-CATH, AND BREVIA SHORT-TERM CURVED EXTENSION HEMODIALYSIS CATHETERS (FDA 510(k) Clearance)

Feb 2009
Decision
28d
Days
Class 2
Risk

K090102 is an FDA 510(k) clearance for the NIAGARA, NIAGARA SLIM-CATH, AND BREVIA SHORT-TERM CURVED EXTENSION HEMODIALYSIS CATHETERS. This device is classified as a Catheter, Hemodialysis, Non-implanted (Class II - Special Controls, product code MPB).

Submitted by C.R. Bard, Inc. (Salt Lake Ciy,, US). The FDA issued a Cleared decision on February 12, 2009, 28 days after receiving the submission on January 15, 2009.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.5540.

Submission Details

510(k) Number K090102 FDA.gov
FDA Decision Cleared Substantially Equivalent - De Novo Granted (SEKD)
Date Received January 15, 2009
Decision Date February 12, 2009
Days to Decision 28 days
Submission Type Special
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code MPB — Catheter, Hemodialysis, Non-implanted
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.5540